Literature DB >> 461173

[Prolactin secreting adenomas: surgical treatment and results. 120 female cases, 30 males cases (author's transl)].

P J Derome, F Peillon, R H Bard, C P Jedynak, J Racadot, G Guiot.   

Abstract

Twenty one per cent of the female cases concerned microadenomas discovered because of amenorrhea with or without galactorrhea. Sixty two per cent of these cases were cured by surgery alone, against 40% of the other types of prolactin (Prl) -- secreting tumors with extra-sellar extensions which were not cured. With men, no microadenomas was discovered (although one case demonstrated their possible existence) and in the most frequent cases, tumors exhibited extra-sellar extensions sometimes very large (giant tumors). In these cases, tumoral symptoms were cured by surgery while only 5 out of 30 men recovered a normal plasma Prl. level (30 ng/ml). In all cases the prognosis was established taking into account the volume and invasive characters (at the surgical and histopathological level) of the tumors. The different therapeutical approaches of these tumors (i.e. medical treatment by CB 154, surgery of Rxtherapy) were evaluated. Anyway the necessity of an earlier diagnosis is pointed out allowing the possibility of a selective adenomectomy by a microsurgical approach.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 461173

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  5 in total

1.  Enlarged adenomectomy for enclosed prolactinomas: a preliminary study of 26 cases.

Authors:  F Grisoli; T Brue; N Graziani; R Costa; J Trouillas; D Begou; P Jaquet
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

2.  Present status of neurosurgery in the treatment of prolactinomas.

Authors:  R Fahlbusch; M Buchfelder
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

3.  Clinical management of prolactinomas: a ten-year experience.

Authors:  B Merola; A Colao; N Panza; E Caruso; R Spaziante; G Schettini; E de Divitiis; G Pacilio; G Lombardi
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

4.  Operative management of chromophobe pituitary tumour recurrences.

Authors:  S Valtonen; J Salmi
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

5.  Diagnostic criteria in pituitary tumour recurrence--combined modality of surgery and radiotherapy.

Authors:  F Rauhut; H E Clar; M Bamberg; G Benker; W Grote
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.